The ‘BARCODE 1’ study calculated the risk of the disease using DNA extracted from saliva.

Findings show the “spit test” is more accurate at identifying those with high genetic risk than the current PSA blood test approach.

It’s hoped the new at-home test could provide a simpler and cheaper method for early diagnosis.